Topoisomerase IV-quinolone interactions are mediated through a water-metal ion bridge: mechanistic basis of quinolone resistance

被引:125
作者
Aldred, Katie J. [1 ]
McPherson, Sylvia A. [2 ]
Turnbough, Charles L., Jr. [2 ]
Kerns, Robert J. [3 ]
Osheroff, Neil [1 ,4 ]
机构
[1] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA
[2] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA
[3] Univ Iowa, Coll Pharm, Div Med & Nat Prod Chem, Iowa City, IA 52242 USA
[4] Vanderbilt Univ, Dept Med Hematol Oncol, Sch Med, Nashville, TN 37232 USA
基金
美国国家卫生研究院;
关键词
DNA GYRASE-A; BACILLUS-ANTHRACIS MUTANTS; IN-VITRO; STAPHYLOCOCCUS-AUREUS; PARC SUBUNIT; STREPTOCOCCUS-PNEUMONIAE; II TOPOISOMERASES; CLEAVAGE REACTION; ESCHERICHIA-COLI; TARGETS;
D O I
10.1093/nar/gkt124
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although quinolones are the most commonly prescribed antibacterials, their use is threatened by an increasing prevalence of resistance. The most common causes of quinolone resistance are mutations of a specific serine or acidic residue in the A subunit of gyrase or topoisomerase IV. These amino acids are proposed to serve as a critical enzyme-quinolone interaction site by anchoring a water-metal ion bridge that coordinates drug binding. To probe the role of the proposed water-metal ion bridge, we characterized wild-type, GrlA(E85K), GrlA(S81F/E85K), GrlA(E85A), GrlA(S81F/E85A) and GrlA(S81F) Bacillus anthracis topoisomerase IV, their sensitivity to quinolones and related drugs and their use of metal ions. Mutations increased the Mg2+ concentration required to produce maximal quinolone-induced DNA cleavage and restricted the divalent metal ions that could support quinolone activity. Individual mutation of Ser81 or Glu85 partially disrupted bridge function, whereas simultaneous mutation of both residues abrogated protein-quinolone interactions. Results provide functional evidence for the existence of the water-metal ion bridge, confirm that the serine and glutamic acid residues anchor the bridge, demonstrate that the bridge is the primary conduit for interactions between clinically relevant quinolones and topoisomerase IV and provide a likely mechanism for the most common causes of quinolone resistance.
引用
收藏
页码:4628 / 4639
页数:12
相关论文
共 65 条
[1]   Drug Interactions with Bacillus anthracis Topoisomerase IV: Biochemical Basis for Quinolone Action and Resistance [J].
Aldred, Katie J. ;
McPherson, Sylvia A. ;
Wang, Pengfei ;
Kerns, Robert J. ;
Graves, David E. ;
Turnbough, Charles L., Jr. ;
Osheroff, Neil .
BIOCHEMISTRY, 2012, 51 (01) :370-381
[2]   Quinolones inhibit DNA religation mediated by Staphylococcus aureus topoisomerase IV -: Changes in drug mechanism across evolutionary boundaries [J].
Anderson, VE ;
Zaniewski, RP ;
Kaczmarek, FS ;
Gootz, TD ;
Osheroff, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (50) :35927-35932
[3]   Action of quinolones against Staphylococcus aureus topoisomerase IV:: Basis for DNA cleavage enhancement [J].
Anderson, VE ;
Zaniewski, RP ;
Kaczmarek, FS ;
Gootz, TD ;
Osheroff, N .
BIOCHEMISTRY, 2000, 39 (10) :2726-2732
[4]   Type II topoisomerases as targets for quinolone antibacterials: turning Dr. Jekyll into Mr. Hyde [J].
Anderson, VE ;
Osheroff, N .
CURRENT PHARMACEUTICAL DESIGN, 2001, 7 (05) :337-353
[5]   The quinolones: Past, present, and future [J].
Andriole, VT .
CLINICAL INFECTIOUS DISEASES, 2005, 41 :S113-S119
[6]   Type II topoisomerase mutations in Bacillus anthracis associated with high-level fluoroquinolone resistance [J].
Bast, DJ ;
Athamna, A ;
Duncan, CL ;
de Azavedo, JCS ;
Low, DE ;
Rahav, G ;
Farrell, D ;
Rubinstein, E .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (01) :90-94
[7]   Type IIA topoisomerase inhibition by a new class of antibacterial agents [J].
Bax, Benjamin D. ;
Chan, Pan F. ;
Eggleston, Drake S. ;
Fosberry, Andrew ;
Gentry, Daniel R. ;
Gorrec, Fabrice ;
Giordano, Ilaria ;
Hann, Michael M. ;
Hennessy, Alan ;
Hibbs, Martin ;
Huang, Jianzhong ;
Jones, Emma ;
Jones, Jo ;
Brown, Kristin Koretke ;
Lewis, Ceri J. ;
May, Earl W. ;
Saunders, Martin R. ;
Singh, Onkar ;
Spitzfaden, Claus E. ;
Shen, Carol ;
Shillings, Anthony ;
Theobald, Andrew J. ;
Wohlkonig, Alexandre ;
Pearson, Neil D. ;
Gwynn, Michael N. .
NATURE, 2010, 466 (7309) :935-U51
[8]   DNA topoisomerases: Structure, function, and mechanism [J].
Champoux, JJ .
ANNUAL REVIEW OF BIOCHEMISTRY, 2001, 70 :369-413
[9]   CLONING AND CHARACTERIZATION OF A DNA GYRASE-A GENE FROM ESCHERICHIA-COLI THAT CONFERS CLINICAL RESISTANCE TO 4-QUINOLONES [J].
CULLEN, ME ;
WYKE, AW ;
KURODA, R ;
FISHER, LM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (06) :886-894
[10]   Human topoisomerase IIα uses a two-metal-ion mechanism for DNA cleavage [J].
Deweese, Joseph E. ;
Burgin, Alex B. ;
Osheroff, Neil .
NUCLEIC ACIDS RESEARCH, 2008, 36 (15) :4883-4893